Search for: "Kevin Madagan"
Results 1 - 20
of 34
Sort by Relevance
|
Sort by Date
6 May 2020, 6:35 am
Reed Smith partner Kevin Madagan and associate Julia Lake will return for a second year to help lead a four-hour “Ad Promo Primer” at the Drug Information Association (DIA)’s “Advertising and Promotion Regulatory Affairs Conference,” which will be held virtually May 18-20, 2020. [read post]
2 Apr 2020, 1:34 pm
Madagan, Paul W. [read post]
2 Apr 2020, 1:33 pm
Madagan, Paul W. [read post]
30 Oct 2017, 12:43 pm
Partner Kevin Madagan of Reed Smith’s Life Science Health Industry group will participate in an exert legal panel discussion at the 2017 Health Care Distribution Alliance (HDA) Traceability Seminar held November 8-10 in Washington D.C. [read post]
27 Jun 2016, 7:46 am
Reed Smith presenters Gail Daubert, Celeste Letourneau and Kevin Madagan will be discussing the increasing popularity of 3D printing and how it is changing the future of health care far more dramatically than we would have ever imagined. [read post]
25 Feb 2015, 6:48 am
Reed Smith attorneys Kevin Madagan and Keri Bruce were recently quoted in the January 21st edition of Compliance Week in an article titled “FTC, FDA Take Closer Look at Disclosures,” which discusses recent actions by the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) concerning advertisement disclosures. [read post]
25 Feb 2015, 6:48 am
Reed Smith attorneys Kevin Madagan and Keri Bruce were recently quoted in the January 21st edition of Compliance Week in an article titled “FTC, FDA Take Closer Look at Disclosures,” which discusses recent actions by the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) concerning advertisement disclosures. [read post]
8 Feb 2015, 6:10 pm
In a recent Compliance Week article, Keri Bruce and Kevin Madagan discuss the FTC’s and FDA’s increased attention to disclosure practices, reminding companies to review their existing measures. [read post]
8 Feb 2015, 6:10 pm
In a recent Compliance Week article, Keri Bruce and Kevin Madagan discuss the FTC’s and FDA’s increased attention to disclosure practices, reminding companies to review their existing measures. [read post]
8 Feb 2015, 6:10 pm
In a recent Compliance Week article, Keri Bruce and Kevin Madagan discuss the FTC’s and FDA’s increased attention to disclosure practices, reminding companies to review their existing measures. [read post]
30 Dec 2014, 7:55 am
Madagan. [read post]
23 Jun 2014, 6:50 am
Earlier this week, the FDA issued two draft guidances on social media, and in this client alert, attorneys Colleen Davies, Celeste Letourneau, Kevin Madagan, and Jennifer Pike have analyzed them both in detail. [read post]
14 Mar 2014, 7:58 am
This post was written by Jillian Riley and Kevin Madagan In only the second Untitled Letter of the year, FDA’s Office of Prescription Drug Promotion warned a Swiss drug company about statements the company made on its Facebook page. [read post]
24 Feb 2014, 2:19 pm
Madagan and Jillian W. [read post]
10 Dec 2013, 9:01 am
This post was written by Kevin Madagan. [read post]
20 Jun 2013, 7:07 am
This post was written by Kevin Madagan and Jennifer Pike. [read post]
5 Jun 2013, 8:33 am
This post was written by Kevin Madagan and Jennifer Pike. [read post]
29 Apr 2013, 6:39 am
Madagan and Jennifer Pike. [read post]
24 Apr 2013, 7:50 am
This post was written by Kevin Madagan and Debra McCurdy. [read post]
21 Oct 2011, 3:35 pm
Kupchyk, Kevin M. [read post]